Global Pertussis Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to APO Research, The global Pertussis Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.
The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to APO Research, The global Pertussis Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.
The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Minhai Biotechnology
- KM Biologics
- Chengdu Institute of Biological Products
- Whole-cell Vaccines
- Acellular Vaccines
- 12 Months Below
- 12 Months Above
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pertussis Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Pertussis Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Pertussis Vaccine Market by Type
1.3.1 Whole-cell Vaccines
1.3.2 Acellular Vaccines
1.4 Global Pertussis Vaccine Market Size by Type
1.4.1 Global Pertussis Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Pertussis Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Pertussis Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Pertussis Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Pertussis Vaccine Revenue (2019-2024)
3.2 Global Top Players by Pertussis Vaccine Sales (2019-2024)
3.3 Global Top Players by Pertussis Vaccine Price (2019-2024)
3.4 Global Pertussis Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Pertussis Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Pertussis Vaccine Company, Product Type & Application
3.7 Global Pertussis Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Pertussis Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier
4 PERTUSSIS VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Pertussis Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Pertussis Vaccine Historic Market Size by Region
4.2.1 Global Pertussis Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Pertussis Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Pertussis Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Pertussis Vaccine Forecasted Market Size by Region
4.3.1 Global Pertussis Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Pertussis Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Pertussis Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 PERTUSSIS VACCINE BY APPLICATION
5.1 Pertussis Vaccine Market by Application
5.1.1 12 Months Below
5.1.2 12 Months Above
5.2 Global Pertussis Vaccine Market Size by Application
5.2.1 Global Pertussis Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Pertussis Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Pertussis Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Pertussis Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Comapny Information
6.1.2 Sanofi Pasteur Business Overview
6.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Pertussis Vaccine Product Portfolio
6.2.5 GSK Recent Developments
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Comapny Information
6.3.2 Mitsubishi Tanabe Pharma Business Overview
6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments
6.4 Wuhan Institute of Biological Products
6.4.1 Wuhan Institute of Biological Products Comapny Information
6.4.2 Wuhan Institute of Biological Products Business Overview
6.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
6.4.5 Wuhan Institute of Biological Products Recent Developments
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Comapny Information
6.5.2 Walvax Biotechnology Business Overview
6.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments
6.6 Minhai Biotechnology
6.6.1 Minhai Biotechnology Comapny Information
6.6.2 Minhai Biotechnology Business Overview
6.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
6.6.5 Minhai Biotechnology Recent Developments
6.7 KM Biologics
6.7.1 KM Biologics Comapny Information
6.7.2 KM Biologics Business Overview
6.7.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 KM Biologics Pertussis Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments
6.8 Chengdu Institute of Biological Products
6.8.1 Chengdu Institute of Biological Products Comapny Information
6.8.2 Chengdu Institute of Biological Products Business Overview
6.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
6.8.5 Chengdu Institute of Biological Products Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Pertussis Vaccine Sales by Country
7.1.1 North America Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Pertussis Vaccine Sales by Country (2019-2024)
7.1.3 North America Pertussis Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Pertussis Vaccine Market Size by Country
7.2.1 North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Pertussis Vaccine Market Size by Country (2019-2024)
7.2.3 North America Pertussis Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Pertussis Vaccine Sales by Country
8.1.1 Europe Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Pertussis Vaccine Sales by Country (2019-2024)
8.1.3 Europe Pertussis Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Pertussis Vaccine Market Size by Country
8.2.1 Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Pertussis Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Pertussis Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Pertussis Vaccine Sales by Country
9.1.1 Asia-Pacific Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Pertussis Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Pertussis Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Pertussis Vaccine Market Size by Country
9.2.1 Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Pertussis Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Pertussis Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Pertussis Vaccine Sales by Country
10.1.1 Latin America Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Pertussis Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Pertussis Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Pertussis Vaccine Market Size by Country
10.2.1 Latin America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Pertussis Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Pertussis Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Pertussis Vaccine Sales by Country
11.1.1 Middle East and Africa Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Pertussis Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Pertussis Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Pertussis Vaccine Market Size by Country
11.2.1 Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Pertussis Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Pertussis Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Pertussis Vaccine Value Chain Analysis
12.1.1 Pertussis Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Pertussis Vaccine Production Mode & Process
12.2 Pertussis Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Pertussis Vaccine Distributors
12.2.3 Pertussis Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pertussis Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Pertussis Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Pertussis Vaccine Market by Type
1.3.1 Whole-cell Vaccines
1.3.2 Acellular Vaccines
1.4 Global Pertussis Vaccine Market Size by Type
1.4.1 Global Pertussis Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Pertussis Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Pertussis Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Pertussis Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Pertussis Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Pertussis Vaccine Revenue (2019-2024)
3.2 Global Top Players by Pertussis Vaccine Sales (2019-2024)
3.3 Global Top Players by Pertussis Vaccine Price (2019-2024)
3.4 Global Pertussis Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Pertussis Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Pertussis Vaccine Company, Product Type & Application
3.7 Global Pertussis Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Pertussis Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier
4 PERTUSSIS VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Pertussis Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Pertussis Vaccine Historic Market Size by Region
4.2.1 Global Pertussis Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Pertussis Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Pertussis Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Pertussis Vaccine Forecasted Market Size by Region
4.3.1 Global Pertussis Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Pertussis Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Pertussis Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 PERTUSSIS VACCINE BY APPLICATION
5.1 Pertussis Vaccine Market by Application
5.1.1 12 Months Below
5.1.2 12 Months Above
5.2 Global Pertussis Vaccine Market Size by Application
5.2.1 Global Pertussis Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Pertussis Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Pertussis Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Pertussis Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Pertussis Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Comapny Information
6.1.2 Sanofi Pasteur Business Overview
6.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Pertussis Vaccine Product Portfolio
6.2.5 GSK Recent Developments
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Comapny Information
6.3.2 Mitsubishi Tanabe Pharma Business Overview
6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments
6.4 Wuhan Institute of Biological Products
6.4.1 Wuhan Institute of Biological Products Comapny Information
6.4.2 Wuhan Institute of Biological Products Business Overview
6.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
6.4.5 Wuhan Institute of Biological Products Recent Developments
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Comapny Information
6.5.2 Walvax Biotechnology Business Overview
6.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments
6.6 Minhai Biotechnology
6.6.1 Minhai Biotechnology Comapny Information
6.6.2 Minhai Biotechnology Business Overview
6.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
6.6.5 Minhai Biotechnology Recent Developments
6.7 KM Biologics
6.7.1 KM Biologics Comapny Information
6.7.2 KM Biologics Business Overview
6.7.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 KM Biologics Pertussis Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments
6.8 Chengdu Institute of Biological Products
6.8.1 Chengdu Institute of Biological Products Comapny Information
6.8.2 Chengdu Institute of Biological Products Business Overview
6.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
6.8.5 Chengdu Institute of Biological Products Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Pertussis Vaccine Sales by Country
7.1.1 North America Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Pertussis Vaccine Sales by Country (2019-2024)
7.1.3 North America Pertussis Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Pertussis Vaccine Market Size by Country
7.2.1 North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Pertussis Vaccine Market Size by Country (2019-2024)
7.2.3 North America Pertussis Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Pertussis Vaccine Sales by Country
8.1.1 Europe Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Pertussis Vaccine Sales by Country (2019-2024)
8.1.3 Europe Pertussis Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Pertussis Vaccine Market Size by Country
8.2.1 Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Pertussis Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Pertussis Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Pertussis Vaccine Sales by Country
9.1.1 Asia-Pacific Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Pertussis Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Pertussis Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Pertussis Vaccine Market Size by Country
9.2.1 Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Pertussis Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Pertussis Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Pertussis Vaccine Sales by Country
10.1.1 Latin America Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Pertussis Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Pertussis Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Pertussis Vaccine Market Size by Country
10.2.1 Latin America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Pertussis Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Pertussis Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Pertussis Vaccine Sales by Country
11.1.1 Middle East and Africa Pertussis Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Pertussis Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Pertussis Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Pertussis Vaccine Market Size by Country
11.2.1 Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Pertussis Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Pertussis Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Pertussis Vaccine Value Chain Analysis
12.1.1 Pertussis Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Pertussis Vaccine Production Mode & Process
12.2 Pertussis Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Pertussis Vaccine Distributors
12.2.3 Pertussis Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Whole-cell Vaccines
Table 2. Major Company of Acellular Vaccines
Table 3. Global Pertussis Vaccine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 5. Global Pertussis Vaccine Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Pertussis Vaccine Sales Market Share in Value by Type (2019-2024)
Table 8. Global Pertussis Vaccine Price by Type (2019-2024) & (USD/Doses)
Table 9. Global Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 10. Global Pertussis Vaccine Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Pertussis Vaccine Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Pertussis Vaccine Sales Market Share in Value by Type (2025-2030)
Table 13. Global Pertussis Vaccine Price by Type (2025-2030) & (USD/Doses)
Table 14. North America Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 15. North America Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 17. Europe Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 19. Asia-Pacific Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 21. Latin America Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 23. Middle East and Africa Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 24. Pertussis Vaccine Industry Trends
Table 25. Pertussis Vaccine Industry Drivers
Table 26. Pertussis Vaccine Industry Opportunities and Challenges
Table 27. Pertussis Vaccine Industry Restraints
Table 28. Global Pertussis Vaccine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Pertussis Vaccine Revenue Market Share by Company (2019-2024)
Table 30. Global Pertussis Vaccine Sales by Company (2019-2024) & (M Doses)
Table 31. Global Pertussis Vaccine Sales Share by Company (2019-2024)
Table 32. Global Pertussis Vaccine Market Price by Company (2019-2024) & (USD/Doses)
Table 33. Global Pertussis Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Pertussis Vaccine Key Company Manufacturing Sites & Headquarters
Table 35. Global Pertussis Vaccine Company, Product Type & Application
Table 36. Global Pertussis Vaccine Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Pertussis Vaccine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
Table 41. Global Pertussis Vaccine Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Pertussis Vaccine Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Pertussis Vaccine Sales Market Share in Value by Region (2019-2024)
Table 44. Global Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 45. Global Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)
Table 46. Global Pertussis Vaccine Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Pertussis Vaccine Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Pertussis Vaccine Sales Market Share in Value by Region (2025-2030)
Table 49. Global Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2025-2030)
Table 50. Global Pertussis Vaccine Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Global Pertussis Vaccine Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Pertussis Vaccine Sales Market Share in Value by Application (2019-2024)
Table 55. Global Pertussis Vaccine Price by Application (2019-2024) & (USD/Doses)
Table 56. Global Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 57. Global Pertussis Vaccine Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Pertussis Vaccine Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Pertussis Vaccine Sales Market Share in Value by Application (2025-2030)
Table 60. Global Pertussis Vaccine Price by Application (2025-2030) & (USD/Doses)
Table 61. North America Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 62. North America Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 64. Europe Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 66. Asia-Pacific Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 68. Latin America Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 70. Middle East and Africa Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 71. Sanofi Pasteur Company Information
Table 72. Sanofi Pasteur Business Overview
Table 73. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 74. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 75. Sanofi Pasteur Recent Development
Table 76. GSK Company Information
Table 77. GSK Business Overview
Table 78. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 79. GSK Pertussis Vaccine Product Portfolio
Table 80. GSK Recent Development
Table 81. Mitsubishi Tanabe Pharma Company Information
Table 82. Mitsubishi Tanabe Pharma Business Overview
Table 83. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 84. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 85. Mitsubishi Tanabe Pharma Recent Development
Table 86. Wuhan Institute of Biological Products Company Information
Table 87. Wuhan Institute of Biological Products Business Overview
Table 88. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 89. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 90. Wuhan Institute of Biological Products Recent Development
Table 91. Walvax Biotechnology Company Information
Table 92. Walvax Biotechnology Business Overview
Table 93. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 94. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 95. Walvax Biotechnology Recent Development
Table 96. Minhai Biotechnology Company Information
Table 97. Minhai Biotechnology Business Overview
Table 98. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 99. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 100. Minhai Biotechnology Recent Development
Table 101. KM Biologics Company Information
Table 102. KM Biologics Business Overview
Table 103. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 104. KM Biologics Pertussis Vaccine Product Portfolio
Table 105. KM Biologics Recent Development
Table 106. Chengdu Institute of Biological Products Company Information
Table 107. Chengdu Institute of Biological Products Business Overview
Table 108. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 109. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 110. Chengdu Institute of Biological Products Recent Development
Table 111. North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 112. North America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 113. North America Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 114. North America Pertussis Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 115. North America Pertussis Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 116. North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 117. North America Pertussis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 118. North America Pertussis Vaccine Market Share by Country (2019-2024)
Table 119. North America Pertussis Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 120. North America Pertussis Vaccine Market Share Forecast by Country (2025-2030)
Table 121. Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 122. Europe Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 123. Europe Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 124. Europe Pertussis Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 125. Europe Pertussis Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 126. Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 127. Europe Pertussis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 128. Europe Pertussis Vaccine Market Share by Country (2019-2024)
Table 129. Europe Pertussis Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 130. Europe Pertussis Vaccine Market Share Forecast by Country (2025-2030)
Table 131. Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 132. Asia-Pacific Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 133. Asia-Pacific Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 134. Asia-Pacific Pertussis Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 135. Asia-Pacific Pertussis Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 136. Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 137. Asia-Pacific Pertussis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 138. Asia-Pacific Pertussis Vaccine Market Share by Country (2019-2024)
Table 139. Asia-Pacific Pertussis Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 140. Asia-Pacific Pertussis Vaccine Market Share Forecast by Country (2025-2030)
Table 141. Latin America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 142. Latin America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 143. Latin America Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 144. Latin America Pertussis Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 145. Latin America Pertussis Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 146. Latin America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 147. Latin America Pertussis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 148. Latin America Pertussis Vaccine Market Share by Country (2019-2024)
Table 149. Latin America Pertussis Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 150. Latin America Pertussis Vaccine Market Share Forecast by Country (2025-2030)
Table 151. Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 152. Middle East and Africa Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 153. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 154. Middle East and Africa Pertussis Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 155. Middle East and Africa Pertussis Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 156. Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 157. Middle East and Africa Pertussis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 158. Middle East and Africa Pertussis Vaccine Market Share by Country (2019-2024)
Table 159. Middle East and Africa Pertussis Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 160. Middle East and Africa Pertussis Vaccine Market Share Forecast by Country (2025-2030)
Table 161. Key Raw Materials
Table 162. Raw Materials Key Suppliers
Table 163. Pertussis Vaccine Distributors List
Table 164. Pertussis Vaccine Customers List
Table 165. Research Programs/Design for This Report
Table 166. Authors List of This Report
Table 167. Secondary Sources
Table 168. Primary Sources
Table 1. Major Company of Whole-cell Vaccines
Table 2. Major Company of Acellular Vaccines
Table 3. Global Pertussis Vaccine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 5. Global Pertussis Vaccine Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Pertussis Vaccine Sales Market Share in Value by Type (2019-2024)
Table 8. Global Pertussis Vaccine Price by Type (2019-2024) & (USD/Doses)
Table 9. Global Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)
Table 10. Global Pertussis Vaccine Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Pertussis Vaccine Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Pertussis Vaccine Sales Market Share in Value by Type (2025-2030)
Table 13. Global Pertussis Vaccine Price by Type (2025-2030) & (USD/Doses)
Table 14. North America Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 15. North America Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 17. Europe Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 19. Asia-Pacific Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 21. Latin America Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)
Table 23. Middle East and Africa Pertussis Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 24. Pertussis Vaccine Industry Trends
Table 25. Pertussis Vaccine Industry Drivers
Table 26. Pertussis Vaccine Industry Opportunities and Challenges
Table 27. Pertussis Vaccine Industry Restraints
Table 28. Global Pertussis Vaccine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Pertussis Vaccine Revenue Market Share by Company (2019-2024)
Table 30. Global Pertussis Vaccine Sales by Company (2019-2024) & (M Doses)
Table 31. Global Pertussis Vaccine Sales Share by Company (2019-2024)
Table 32. Global Pertussis Vaccine Market Price by Company (2019-2024) & (USD/Doses)
Table 33. Global Pertussis Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Pertussis Vaccine Key Company Manufacturing Sites & Headquarters
Table 35. Global Pertussis Vaccine Company, Product Type & Application
Table 36. Global Pertussis Vaccine Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Pertussis Vaccine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)
Table 41. Global Pertussis Vaccine Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Pertussis Vaccine Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Pertussis Vaccine Sales Market Share in Value by Region (2019-2024)
Table 44. Global Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 45. Global Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)
Table 46. Global Pertussis Vaccine Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Pertussis Vaccine Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Pertussis Vaccine Sales Market Share in Value by Region (2025-2030)
Table 49. Global Pertussis Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2025-2030)
Table 50. Global Pertussis Vaccine Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Global Pertussis Vaccine Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Pertussis Vaccine Sales Market Share in Value by Application (2019-2024)
Table 55. Global Pertussis Vaccine Price by Application (2019-2024) & (USD/Doses)
Table 56. Global Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)
Table 57. Global Pertussis Vaccine Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Pertussis Vaccine Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Pertussis Vaccine Sales Market Share in Value by Application (2025-2030)
Table 60. Global Pertussis Vaccine Price by Application (2025-2030) & (USD/Doses)
Table 61. North America Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 62. North America Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 64. Europe Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 66. Asia-Pacific Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 68. Latin America Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)
Table 70. Middle East and Africa Pertussis Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 71. Sanofi Pasteur Company Information
Table 72. Sanofi Pasteur Business Overview
Table 73. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 74. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 75. Sanofi Pasteur Recent Development
Table 76. GSK Company Information
Table 77. GSK Business Overview
Table 78. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 79. GSK Pertussis Vaccine Product Portfolio
Table 80. GSK Recent Development
Table 81. Mitsubishi Tanabe Pharma Company Information
Table 82. Mitsubishi Tanabe Pharma Business Overview
Table 83. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 84. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 85. Mitsubishi Tanabe Pharma Recent Development
Table 86. Wuhan Institute of Biological Products Company Information
Table 87. Wuhan Institute of Biological Products Business Overview
Table 88. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 89. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 90. Wuhan Institute of Biological Products Recent Development
Table 91. Walvax Biotechnology Company Information
Table 92. Walvax Biotechnology Business Overview
Table 93. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 94. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 95. Walvax Biotechnology Recent Development
Table 96. Minhai Biotechnology Company Information
Table 97. Minhai Biotechnology Business Overview
Table 98. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 99. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 100. Minhai Biotechnology Recent Development
Table 101. KM Biologics Company Information
Table 102. KM Biologics Business Overview
Table 103. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 104. KM Biologics Pertussis Vaccine Product Portfolio
Table 105. KM Biologics Recent Development
Table 106. Chengdu Institute of Biological Products Company Information
Table 107. Chengdu Institute of Biological Products Business Overview
Table 108. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 109. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 110. Chengdu Institute of Biological Products Recent Development
Table 111. North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 112. North America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 113. North America Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 114. North America Pertussis Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 115. North America Pertussis Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 116. North America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 117. North America Pertussis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 118. North America Pertussis Vaccine Market Share by Country (2019-2024)
Table 119. North America Pertussis Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 120. North America Pertussis Vaccine Market Share Forecast by Country (2025-2030)
Table 121. Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 122. Europe Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 123. Europe Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 124. Europe Pertussis Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 125. Europe Pertussis Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 126. Europe Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 127. Europe Pertussis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 128. Europe Pertussis Vaccine Market Share by Country (2019-2024)
Table 129. Europe Pertussis Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 130. Europe Pertussis Vaccine Market Share Forecast by Country (2025-2030)
Table 131. Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 132. Asia-Pacific Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 133. Asia-Pacific Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 134. Asia-Pacific Pertussis Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 135. Asia-Pacific Pertussis Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 136. Asia-Pacific Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 137. Asia-Pacific Pertussis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 138. Asia-Pacific Pertussis Vaccine Market Share by Country (2019-2024)
Table 139. Asia-Pacific Pertussis Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 140. Asia-Pacific Pertussis Vaccine Market Share Forecast by Country (2025-2030)
Table 141. Latin America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 142. Latin America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 143. Latin America Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 144. Latin America Pertussis Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 145. Latin America Pertussis Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 146. Latin America Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 147. Latin America Pertussis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 148. Latin America Pertussis Vaccine Market Share by Country (2019-2024)
Table 149. Latin America Pertussis Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 150. Latin America Pertussis Vaccine Market Share Forecast by Country (2025-2030)
Table 151. Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 152. Middle East and Africa Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)
Table 153. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2019-2024)
Table 154. Middle East and Africa Pertussis Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 155. Middle East and Africa Pertussis Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 156. Middle East and Africa Pertussis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 157. Middle East and Africa Pertussis Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 158. Middle East and Africa Pertussis Vaccine Market Share by Country (2019-2024)
Table 159. Middle East and Africa Pertussis Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 160. Middle East and Africa Pertussis Vaccine Market Share Forecast by Country (2025-2030)
Table 161. Key Raw Materials
Table 162. Raw Materials Key Suppliers
Table 163. Pertussis Vaccine Distributors List
Table 164. Pertussis Vaccine Customers List
Table 165. Research Programs/Design for This Report
Table 166. Authors List of This Report
Table 167. Secondary Sources
Table 168. Primary Sources
LIST OF FIGURES
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pertussis Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Pertussis Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Product Picture of Whole-cell Vaccines
Figure 6. Global Whole-cell Vaccines Sales YoY Growth (2019-2030) & (M Doses)
Figure 7. Product Picture of Acellular Vaccines
Figure 8. Global Acellular Vaccines Sales YoY Growth (2019-2030) & (M Doses)
Figure 9. Global Pertussis Vaccine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Pertussis Vaccine Market Share by Type 2023 VS 2030
Figure 11. North America Pertussis Vaccine Sales Market Share in Volume by Type in 2023
Figure 12. North America Pertussis Vaccine Sales Market Share in Value by Type in 2023
Figure 13. Europe Pertussis Vaccine Sales Market Share in Volume by Type in 2023
Figure 14. Europe Pertussis Vaccine Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Pertussis Vaccine Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Pertussis Vaccine Sales Market Share in Value by Type in 2023
Figure 17. Latin America Pertussis Vaccine Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Pertussis Vaccine Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Pertussis Vaccine Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Pertussis Vaccine Sales Market Share in Value by Type in 2023
Figure 21. Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2023
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Product Picture of 12 Months Below
Figure 24. Global 12 Months Below Sales YoY Growth (2019-2030) & (M Doses)
Figure 25. Product Picture of 12 Months Above
Figure 26. Global 12 Months Above Sales YoY Growth (2019-2030) & (M Doses)
Figure 27. Global Pertussis Vaccine Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 28. Global Pertussis Vaccine Market Share by Application 2023 VS 2030
Figure 29. North America Pertussis Vaccine Sales Market Share in Volume by Application in 2023
Figure 30. North America Pertussis Vaccine Sales Market Share in Value by Application in 2023
Figure 31. Europe Pertussis Vaccine Sales Market Share in Volume by Application in 2023
Figure 32. Europe Pertussis Vaccine Sales Market Share in Value by Application in 2023
Figure 33. Asia-Pacific Pertussis Vaccine Sales Market Share in Volume by Application in 2023
Figure 34. Asia-Pacific Pertussis Vaccine Sales Market Share in Value by Application in 2023
Figure 35. Latin America Pertussis Vaccine Sales Market Share in Volume by Application in 2023
Figure 36. Latin America Pertussis Vaccine Sales Market Share in Value by Application in 2023
Figure 37. Middle East and Africa Pertussis Vaccine Sales Market Share in Volume by Application in 2023
Figure 38. Middle East and Africa Pertussis Vaccine Sales Market Share in Value by Application in 2023
Figure 39. North America Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 40. North America Pertussis Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 41. North America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Pertussis Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. Europe Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 44. Europe Pertussis Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 46. Europe Pertussis Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 47. Asia-Pacific Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 48. Asia-Pacific Pertussis Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Asia-Pacific Pertussis Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. Latin America Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 52. Latin America Pertussis Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 53. Latin America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Latin America Pertussis Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East and Africa Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 56. Middle East and Africa Pertussis Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 57. Middle East and Africa Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 58. Middle East and Africa Pertussis Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 59. Pertussis Vaccine Value Chain
Figure 60. Key Raw Materials Price
Figure 61. Manufacturing Cost Structure
Figure 62. Pertussis Vaccine Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pertussis Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Pertussis Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Product Picture of Whole-cell Vaccines
Figure 6. Global Whole-cell Vaccines Sales YoY Growth (2019-2030) & (M Doses)
Figure 7. Product Picture of Acellular Vaccines
Figure 8. Global Acellular Vaccines Sales YoY Growth (2019-2030) & (M Doses)
Figure 9. Global Pertussis Vaccine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Pertussis Vaccine Market Share by Type 2023 VS 2030
Figure 11. North America Pertussis Vaccine Sales Market Share in Volume by Type in 2023
Figure 12. North America Pertussis Vaccine Sales Market Share in Value by Type in 2023
Figure 13. Europe Pertussis Vaccine Sales Market Share in Volume by Type in 2023
Figure 14. Europe Pertussis Vaccine Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Pertussis Vaccine Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Pertussis Vaccine Sales Market Share in Value by Type in 2023
Figure 17. Latin America Pertussis Vaccine Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Pertussis Vaccine Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Pertussis Vaccine Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Pertussis Vaccine Sales Market Share in Value by Type in 2023
Figure 21. Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2023
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Product Picture of 12 Months Below
Figure 24. Global 12 Months Below Sales YoY Growth (2019-2030) & (M Doses)
Figure 25. Product Picture of 12 Months Above
Figure 26. Global 12 Months Above Sales YoY Growth (2019-2030) & (M Doses)
Figure 27. Global Pertussis Vaccine Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 28. Global Pertussis Vaccine Market Share by Application 2023 VS 2030
Figure 29. North America Pertussis Vaccine Sales Market Share in Volume by Application in 2023
Figure 30. North America Pertussis Vaccine Sales Market Share in Value by Application in 2023
Figure 31. Europe Pertussis Vaccine Sales Market Share in Volume by Application in 2023
Figure 32. Europe Pertussis Vaccine Sales Market Share in Value by Application in 2023
Figure 33. Asia-Pacific Pertussis Vaccine Sales Market Share in Volume by Application in 2023
Figure 34. Asia-Pacific Pertussis Vaccine Sales Market Share in Value by Application in 2023
Figure 35. Latin America Pertussis Vaccine Sales Market Share in Volume by Application in 2023
Figure 36. Latin America Pertussis Vaccine Sales Market Share in Value by Application in 2023
Figure 37. Middle East and Africa Pertussis Vaccine Sales Market Share in Volume by Application in 2023
Figure 38. Middle East and Africa Pertussis Vaccine Sales Market Share in Value by Application in 2023
Figure 39. North America Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 40. North America Pertussis Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 41. North America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Pertussis Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. Europe Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 44. Europe Pertussis Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 46. Europe Pertussis Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 47. Asia-Pacific Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 48. Asia-Pacific Pertussis Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Asia-Pacific Pertussis Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. Latin America Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 52. Latin America Pertussis Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 53. Latin America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Latin America Pertussis Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East and Africa Pertussis Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 56. Middle East and Africa Pertussis Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 57. Middle East and Africa Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 58. Middle East and Africa Pertussis Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 59. Pertussis Vaccine Value Chain
Figure 60. Key Raw Materials Price
Figure 61. Manufacturing Cost Structure
Figure 62. Pertussis Vaccine Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
